Abstract: There appear to be huge variations and aberrations in the reported data in COVID-19 two years now into the pandemic. Conflicting data exist at almost every level and also in the reported epidemiological statistics across different regions. It is becoming clear that COVID-19 is a polymorphic inflammatory spectrum of diseases and there is a wide range of inflammation-related pathology and symptoms in those infected with the virus. The host’s inflammatory response to COVID-19 appears to be determined by genetics, age, immune status, health status and stage of disease. The interplay of these factors may decide the magnitude, duration, types of pathology, symptoms, and prognosis in the spectrum of COVID-19 disorders, and whether neuropsychiatric disorders continue to be significant. Early and successful management of inflammation reduces morbidity and mortality in all stages of COVID-19.
Tang SW, Helmeste DM, Leonard BE. COVID-19 AS A POLYMORPHIC INFLAMMATORY SPECTRUM OF DISEASES: A REVIEW WITH FOCUS ON THE BRAIN. Acta Neuropsychiatr. 2023 Mar 2:1-70. doi: 10.1017/neu.2023.17. Epub ahead of print. PMID: 36861428.
